Dr. Cheepsattayakorn graduated Doctor of Medicine from Chiang Mai Medical School, Chiang Mai University, Chiang Mai, Thailand in 1986. He then further had trained in Internal Medicine, Pulmonology, and Radiology at Chiang Mai University Medical School. Recently, on October 26, 2019, he as bestowed the Gold Medal Award (First-Class Award) from the Chiang Mai University Medical School Alumni Association in Chiang Mai, Thailand for his academic and medical practice excellence for cerebrating the 60th Anniversary of the Chiang Mai University Medical School, Chiang Mai, Thailand that was established on October 28, 1959. He has numerous certified Fellowships from the Royal Colleges of Physicians of Edinburgh, London, and Thailand, Royal College of Physicians and Surgeons of Glasgow, American College of Physicians, and American College of Chest Physicians. Presently, he serves both the Editor and Editorial Board Member and also the referee of several international journals. He has very high experience in the fields of Pulmonary Diseases and Tuberculosis including Infectious Diseases and Immunology. He has numerous scientific publications, more than 190 publications both in national and international journals and books. He had been served a Director and Consultant in Respiratory Medicine of the 10th Zonal Tuberculosis and Chest Diseases Center, Chiang Mai, Thailand for a long time, a Director of the 5th Office of Disease Prevention and Control and Consultant in Respiratory Medicine, Ratchaburi, Thailand and presently serves as Consultant in Respiratory Medicine (Pulmonologist) at the 10th Zonal Tuberculosis and Chest Diseases Center, Chiang Mai, Thailand and Senior Expert Level 11 (Highest Level), Department of Disease Control, Ministry of Public Health, Thailand. Currently, he also serves the Regional Adviser for Thailand of the Royal College of Physicians of Edinburgh, United Kingdom, and the Reviewer for the journals of the Royal College of Physicians of London, United Kingdom.
Dr. Cheepsattayakorn research interests include Nontuberculous mycobacterial infection in HIV-infected patients, Multidrug-resistant tuberculosis patterns in HIV-infected patients, Chemokine gene polymorphisms and their susceptibility to tuberculosis, Breath Tests in Respiratory and Critical Care Medicine, Tropical Infectious Diseases, Human Genetics, and Infectious Diseases, Lung Cancer, COPD, Dengue Virus Infection, Silicosis, and Silicosis-Associated Tuberculosis and COVID-19 Immunogenetics.